BRIDGEWAY CAPITAL MANAGEMENT, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32,544
-77.6%
106,700
-48.4%
0.00%
-66.7%
Q2 2023$145,517
+52.1%
206,700
+93.7%
0.00%0.0%
Q1 2023$95,699
-55.3%
106,700
+214.7%
0.00%
-40.0%
Q2 2022$214,000
-72.5%
33,900
-63.9%
0.01%
-66.7%
Q1 2022$779,000
+16.4%
93,900
-27.2%
0.02%
+25.0%
Q4 2021$669,000
-22.3%
128,9000.0%0.01%
-25.0%
Q3 2021$861,000
-21.6%
128,9000.0%0.02%
-20.0%
Q2 2021$1,098,000
-21.2%
128,900
+37.9%
0.02%
+5.3%
Q4 2019$1,393,000
+45.4%
93,5000.0%0.02%
+46.2%
Q3 2019$958,000
-3.3%
93,5000.0%0.01%0.0%
Q2 2019$991,000
-24.2%
93,5000.0%0.01%
-18.8%
Q1 2019$1,307,000
+37.6%
93,5000.0%0.02%
+23.1%
Q4 2018$950,000
-15.3%
93,5000.0%0.01%
+18.2%
Q3 2018$1,122,000
-1.7%
93,5000.0%0.01%
-8.3%
Q2 2018$1,141,000
+23.9%
93,5000.0%0.01%
+20.0%
Q1 2018$921,000
-5.7%
93,500
+33.6%
0.01%
-9.1%
Q4 2017$977,000
+26.9%
70,0000.0%0.01%
+22.2%
Q3 2017$770,000
+39.2%
70,0000.0%0.01%
+28.6%
Q2 2017$553,000
+60.8%
70,000
+133.3%
0.01%
+75.0%
Q1 2017$344,000
-17.3%
30,000
-15.9%
0.00%
-20.0%
Q4 2016$416,000
-13.0%
35,6650.0%0.01%
-28.6%
Q3 2016$478,000
+51.7%
35,665
+124.3%
0.01%
+40.0%
Q2 2016$315,00015,9000.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders